Perceptive Advisors’s Foamix Pharmaceuticals FOMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-11,203,881
Closed -$37.3M – 139
2019
Q4
$37.3M Hold
11,203,881
– – 0.74% 35
2019
Q3
$34.1M Buy
11,203,881
+6,542,057
+140% +$18.4M 0.92% 30
2019
Q2
$11.1M Hold
4,661,824
– – 0.25% 61
2019
Q1
$17.5M Hold
4,661,824
– – 0.49% 42
2018
Q4
$15.8M Buy
4,661,824
+1,554,400
+50% +$6.76M 0.6% 41
2018
Q3
$17.8M Buy
3,107,424
+1,990,100
+178% +$11.4M 0.48% 44
2018
Q2
$5.6M Hold
1,117,324
– – 0.15% 72
2018
Q1
$5.73M Hold
1,117,324
– – 0.16% 79
2017
Q4
$6.72M Hold
1,117,324
– – 0.22% 68
2017
Q3
$6.2M Hold
1,117,324
– – 0.24% 62
2017
Q2
$5.18M Sell
1,117,324
-205,670
-16% -$918K 0.26% 66
2017
Q1
$6.55M Hold
1,322,994
– – 0.37% 53
2016
Q4
$14.7M Sell
1,322,994
-50,290
-4% -$473K 1.04% 24
2016
Q3
$12.7M Buy
1,373,284
+578,284
+73% +$4.83M 0.82% 30
2016
Q2
$5.05M Buy
+795,000
New +$5.28M 0.35% 57

Perceptive Advisors's FOMX Position: Q1 2020 in Review

Perceptive Advisors sold out of Foamix Pharmaceuticals (FOMX) in Q1 2020, closing a stake of 11,203,881 shares — an estimated $37.3M sold.

Perceptive Advisors first reported a position in FOMX in Q2 2016 and held it in 15 quarters. The position peaked at $37.3M in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • Perceptive Advisors reported no remaining Foamix Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Perceptive Advisors sold 11,203,881 Foamix Pharmaceuticals shares in Q1 2020, an estimated $37.3M.
  • Perceptive Advisors first reported a position in Foamix Pharmaceuticals in Q2 2016 and held it in 15 quarters.
  • Perceptive Advisors's Foamix Pharmaceuticals position peaked at $37.3M in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals as of Q1 2020.

Based on Perceptive Advisors's 13F filing for Q1 2020, filed 15 May 2020.